Profile data is unavailable for this security.
About the company
Micro-Tech Nanjing Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of minimally invasive medical devices. The Company's main products include three series of endoscopic diagnosis and treatment instruments used with endoscopes, microwave ablation equipment and consumables, and disposable endoscopes. Endoscopic diagnosis and treatment equipment mainly includes biopsy, hemostasis and closure, Endoscopic Mucosal Resection (EMR)/Endoscopic Submucosal Dissection (ESD), dilation, and Endoscopic Retrograde Cholangiopancreatography (ERCP), Endoscopic Ultrasonography (EUS) and Endobronchial Ultrasound (EBUS) products. Microwave ablation mainly includes microwave ablation instrument and microwave ablation needle series products. Disposable endoscope mainly includes disposable biliopancreatic imaging system (choledochoscope) and related consumables and other products.
- Revenue in CNY (TTM)2.68bn
- Net income in CNY550.49m
- Incorporated2000
- Employees2.40k
- LocationMicro-Tech Nanjing Co LtdNo. 10, Gaoke 3rd RoadNanjing High-tech Development ZoneNANJING 210032ChinaCHN
- Phone+86 2 558648819
- Fax+86 2 558744269
- Websitehttp://www.micro-tech.com.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Qingdao Haier Biomedical Co Ltd | 2.24bn | 358.01m | 11.05bn | 2.64k | 30.83 | 2.57 | -- | 4.94 | 1.13 | 1.13 | 7.04 | 13.53 | 0.4018 | 5.12 | 6.38 | 848,473.70 | 6.56 | 11.49 | 8.29 | 15.22 | 47.82 | 49.98 | 16.34 | 25.20 | 2.53 | -- | 0.0316 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Shinva Medical Instrument Co Ltd | 10.12bn | 692.34m | 11.11bn | 8.21k | 12.96 | 1.48 | -- | 1.10 | 1.41 | 1.41 | 18.31 | 12.34 | 0.6775 | 2.20 | 4.96 | 1,232,589.00 | 4.72 | 4.63 | 9.14 | 10.76 | 25.62 | 24.22 | 6.96 | 6.12 | 0.8303 | -- | 0.1637 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 61.86 |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.28bn | 154.60m | 11.55bn | 2.21k | 74.83 | 2.95 | -- | 8.99 | 0.3858 | 0.3858 | 3.20 | 9.78 | 0.2524 | 0.6714 | 4.03 | 581,131.60 | 3.14 | 10.97 | 3.95 | 13.69 | 62.40 | 77.33 | 12.43 | 27.08 | 3.62 | -- | 0.0096 | 17.90 | -30.55 | 1.17 | -79.36 | -19.11 | -4.31 | -- |
| Shanghai Runda Medical Technology Co Ltd | 8.43bn | 40.27m | 11.91bn | 3.32k | 295.31 | 2.77 | -- | 1.41 | 0.0673 | 0.0673 | 13.61 | 7.17 | 0.5831 | 4.19 | 1.49 | 2,543,990.00 | 1.18 | 4.78 | 3.13 | 12.86 | 25.94 | 27.13 | 2.03 | 6.36 | 1.01 | 3.04 | 0.5609 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Beijing Wandong Medical Technolgy Co Ltd | 1.40bn | 184.09m | 12.30bn | 1.06k | 66.79 | 2.60 | -- | 8.76 | 0.262 | 0.262 | 2.00 | 6.74 | 0.2647 | 2.76 | 4.01 | 1,325,746.00 | 3.50 | 5.30 | 3.91 | 6.21 | 38.83 | 45.21 | 13.22 | 16.46 | 9.48 | -- | 0.0179 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.27bn | 657.34m | 13.31bn | 908.00 | 19.85 | 3.42 | -- | 10.50 | 5.44 | 5.44 | 10.59 | 31.54 | 0.371 | 1.33 | 6.51 | 1,396,816.00 | 19.00 | 17.68 | 21.55 | 19.43 | 74.51 | 76.60 | 51.21 | 42.25 | 5.49 | -- | 0.0067 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Sansure Biotech Inc | 1.41bn | 259.42m | 13.73bn | 2.01k | 52.67 | 1.87 | -- | 9.76 | 0.4475 | 0.4475 | 2.44 | 12.62 | 0.1667 | 0.878 | 2.03 | 701,473.70 | 2.52 | 26.74 | 2.79 | 30.97 | 76.43 | 67.47 | 15.12 | 42.01 | 7.45 | -- | 0.0583 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.75bn | 430.21m | 13.85bn | 2.16k | 35.40 | 2.74 | -- | 5.04 | 1.86 | 1.86 | 11.89 | 24.07 | 0.3833 | 1.60 | 7.60 | 1,272,966.00 | 5.60 | 4.84 | 6.60 | 5.50 | 68.97 | 72.04 | 14.61 | 16.36 | 3.71 | -- | 0.0697 | 36.86 | 24.59 | 11.24 | 130.58 | 0.0762 | 11.96 | -- |
| Micro-Tech Nanjing Co Ltd | 2.68bn | 550.49m | 13.87bn | 2.40k | 25.12 | 3.72 | -- | 5.18 | 2.94 | 2.94 | 14.30 | 19.86 | 0.6118 | 1.65 | 6.80 | 1,114,222.00 | 12.87 | 10.74 | 15.26 | 12.82 | 66.04 | 63.04 | 21.04 | 19.37 | 3.99 | -- | 0.0183 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
| iRay Technology Co Ltd | 1.82bn | 564.72m | 16.13bn | 1.66k | 30.18 | 3.51 | -- | 8.84 | 3.74 | 3.74 | 12.14 | 32.15 | 0.2544 | 1.03 | 2.56 | 1,097,588.00 | 7.81 | 12.07 | 8.48 | 13.86 | 53.92 | 55.59 | 30.71 | 34.51 | 4.23 | -- | 0.3972 | 31.52 | 20.31 | 33.51 | -5.27 | 58.58 | 107.96 | -- |
Data as of Nov 22 2024. Currency figures normalised to Micro-Tech Nanjing Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
18.11%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Schroder Investment Management (Hong Kong) Ltd.as of 15 Jul 2024 | 6.74m | 3.66% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2024 | 5.31m | 2.88% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 08 Feb 2024 | 5.28m | 2.87% |
| E Fund Management Co., Ltd.as of 08 Feb 2024 | 4.82m | 2.61% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2024 | 2.84m | 1.54% |
| Hwabao WP Fund Management Co., Ltd.as of 08 Feb 2024 | 2.70m | 1.46% |
| Zhong Geng Fund Management Co. , Ltd.as of 30 Jun 2024 | 2.41m | 1.31% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.18m | 0.64% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 1.12m | 0.61% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 972.87k | 0.53% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
